COVID-19 and Obesity: Epidemiology, Pathogenesis and Treatment.
Diabetes Metab Syndr Obes
; 13: 4953-4959, 2020.
Artículo
en Inglés
| MEDLINE | ID: covidwho-2289053
ABSTRACT
The growing prevalence of overweight and obesity has been a worldwide public health issue. During the COVID-19 pandemic, obesity is associated with a higher risk of severity and a worse clinical outcome of SARS-COV-2 infection. This may be because of the chronic low-grade inflammation, impaired immune response and metabolic disorders in obese patients. In this narrative review, we have summarized the association between obesity and COVID-19 and discussed the potential pathogenesis and treatment in these patients. This work may provide practical suggestions on the clinical management of obese COVID-19 patients.
Texto completo:
Disponible
Colección:
Bases de datos internacionales
Base de datos:
MEDLINE
Tipo de estudio:
Estudio observacional
/
Estudio pronóstico
/
Revisiones
Idioma:
Inglés
Revista:
Diabetes Metab Syndr Obes
Año:
2020
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS